[go: up one dir, main page]

DK3567034T3 - Pentacyclothienyl- og indanyl-urinstof-derivater som kaliumkanalåbnere - Google Patents

Pentacyclothienyl- og indanyl-urinstof-derivater som kaliumkanalåbnere Download PDF

Info

Publication number
DK3567034T3
DK3567034T3 DK19179900.6T DK19179900T DK3567034T3 DK 3567034 T3 DK3567034 T3 DK 3567034T3 DK 19179900 T DK19179900 T DK 19179900T DK 3567034 T3 DK3567034 T3 DK 3567034T3
Authority
DK
Denmark
Prior art keywords
pentacyclothienyl
indanyl
potassium channel
channel openers
urine derivatives
Prior art date
Application number
DK19179900.6T
Other languages
English (en)
Inventor
Michael Bös
Original Assignee
Acousia Therapeutics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acousia Therapeutics Gmbh filed Critical Acousia Therapeutics Gmbh
Application granted granted Critical
Publication of DK3567034T3 publication Critical patent/DK3567034T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/26Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40Y being a hydrogen or a carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43Y being a hetero atom
    • C07C323/44X or Y being nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/63Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
  • Fertilizers (AREA)
DK19179900.6T 2017-02-28 2018-02-27 Pentacyclothienyl- og indanyl-urinstof-derivater som kaliumkanalåbnere DK3567034T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17158326.3A EP3366683A1 (en) 2017-02-28 2017-02-28 Cyclic amides, acteamides and ureas useful as potassium channel openers
EP18707374.7A EP3484863B1 (en) 2017-02-28 2018-02-27 Cyclic amides as potassium channel openers

Publications (1)

Publication Number Publication Date
DK3567034T3 true DK3567034T3 (da) 2021-01-11

Family

ID=58192162

Family Applications (2)

Application Number Title Priority Date Filing Date
DK18707374.7T DK3484863T3 (da) 2017-02-28 2018-02-27 Cykliske amider som kaliumkanalåbnere
DK19179900.6T DK3567034T3 (da) 2017-02-28 2018-02-27 Pentacyclothienyl- og indanyl-urinstof-derivater som kaliumkanalåbnere

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK18707374.7T DK3484863T3 (da) 2017-02-28 2018-02-27 Cykliske amider som kaliumkanalåbnere

Country Status (25)

Country Link
US (2) US11034665B2 (da)
EP (3) EP3366683A1 (da)
JP (3) JP6795713B2 (da)
KR (2) KR102382795B1 (da)
CN (2) CN114105942B (da)
AU (2) AU2018227005B2 (da)
BR (2) BR122020025103B1 (da)
CA (2) CA3238405A1 (da)
CL (2) CL2019002445A1 (da)
CY (2) CY1123114T1 (da)
DK (2) DK3484863T3 (da)
ES (2) ES2813064T3 (da)
HR (2) HRP20201159T1 (da)
HU (2) HUE052703T2 (da)
IL (1) IL268931B (da)
LT (2) LT3567034T (da)
MX (2) MX390303B (da)
PH (1) PH12019550146A1 (da)
PL (2) PL3567034T3 (da)
PT (2) PT3567034T (da)
RS (2) RS60648B1 (da)
SI (2) SI3484863T1 (da)
SM (2) SMT202000471T1 (da)
WO (1) WO2018158256A2 (da)
ZA (1) ZA201905198B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3366683A1 (en) * 2017-02-28 2018-08-29 Acousia Therapeutics GmbH Cyclic amides, acteamides and ureas useful as potassium channel openers
US12370176B2 (en) 2019-09-17 2025-07-29 Biohaven Therapeutics Ltd. Methods of use for KV7 channel activators
JP2023523402A (ja) 2020-04-29 2023-06-05 イドーシア ファーマシューティカルズ リミテッド スピロウレア誘導体
US20230303486A1 (en) 2020-06-25 2023-09-28 Idorsia Pharmaceuticals Ltd Cyclobutyl-urea derivatives
AU2021380914B2 (en) * 2020-11-19 2024-08-15 Acousia Therapeutics Gmbh Non-aqueous gel composition
CN116535353A (zh) * 2022-01-25 2023-08-04 上海挚盟医药科技有限公司 作为钾通道调节剂的酰胺类化合物及其制备和应用
EP4279061A1 (en) * 2022-05-18 2023-11-22 Acousia Therapeutics GmbH Aqueous gel composition

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0594034A (ja) 1990-06-29 1993-04-16 Xerox Corp クラツクのない電子写真画像形成デバイス
EP0957099B1 (en) * 1998-04-15 2002-11-20 Pfizer Products Inc. Heterocyclic carboxamides
DE19929076A1 (de) * 1999-06-25 2000-12-28 Aventis Pharma Gmbh Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10061876A1 (de) * 2000-12-12 2002-06-20 Aventis Pharma Gmbh Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
US20020183395A1 (en) 2001-04-04 2002-12-05 Wyeth Methods for treating hyperactive gastric motility
US7273866B2 (en) * 2002-12-20 2007-09-25 Bristol-Myers Squibb Company 2-aryl thiazole derivatives as KCNQ modulators
EP1613303A1 (en) 2003-03-21 2006-01-11 H. Lundbeck A/S Substituted p-diaminobenzene derivatives
TWI357901B (en) 2004-03-12 2012-02-11 Lundbeck & Co As H Substituted morpholine and thiomorpholine derivati
UA89503C2 (uk) 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
US20060188445A1 (en) 2005-02-22 2006-08-24 Fred Hutchinson Cancer Research Center Assay for compounds that protect against sensory hair cell death and compounds identified by same
US7790770B2 (en) * 2005-11-23 2010-09-07 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2007087424A2 (en) 2006-01-25 2007-08-02 The Johns Hopkins University Method of treating kcnq related disorders using organozinc compounds
WO2007138112A2 (en) * 2006-06-01 2007-12-06 Devgen N.V. Compounds that interact with ion channels, in particular with ion channels from the kv family
US20090118274A1 (en) * 2007-02-15 2009-05-07 Darin Allen Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
DE102007032436B4 (de) 2007-07-10 2009-07-16 Heraeus Electro-Nite International N.V. Vorrichtung zum Sammeln von Gasen in Metallschmelzen
CA2694887A1 (en) * 2007-08-01 2009-02-05 Henriette Husum Bak-Jensen Use of kncq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted
EP2212283B1 (en) 2007-10-17 2011-09-21 Sanofi Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
CA2707492A1 (en) * 2007-12-13 2009-06-18 Amgen Inc. Gamma secretase modulators
US7786171B2 (en) * 2008-04-04 2010-08-31 Abbott Laboratories Amide derivatives as positive allosteric modulators and methods of use thereof
TW201038572A (en) * 2009-03-25 2010-11-01 Gruenenthal Gmbh Substituted spiro-amide compounds
AR078126A1 (es) * 2009-06-04 2011-10-19 Merz Pharma Gmbh & Co Kgaa Antagonistas de glicina b, composiciones farmaceuticas, usos y proceso de preparacion de los mismos
WO2011085351A2 (en) * 2010-01-11 2011-07-14 The Johns Hopkins University Method of treating kcnq related disorders
DE102010007281A1 (de) * 2010-02-08 2011-08-11 EMC microcollections GmbH, 72070 Neue Aminoalkyl-oxazol- und Aminoalkyl-thiazolcarbonsäureamide und ihre Anwendung zur Stimulation der endogenen situ Regeneration von Haarsinneszellen im Corti'schen Organ des Innenohres beim Säuger
US8586604B2 (en) * 2010-08-20 2013-11-19 Boehringer Ingelheim International Gmbh Inhibitors of the microsomal prostaglandin E2 synthase-1
TW201217312A (en) 2010-09-22 2012-05-01 Gruenenthal Gmbh Substituted benzamide compounds
ES2656972T3 (es) * 2012-02-23 2018-03-01 Vanderbilt University Análogos de 5-aminotieno [2,3-c] piridazin-6-carboxamida como moduladores alostéricos positivos del receptor de acetilcolina muscarínico M4
EP2900674B1 (en) 2012-09-28 2017-05-31 University of Washington through its Center for Commercialization Compounds and methods for preventing, treating and/or protecting against sensory hair cell death
WO2014079850A1 (en) 2012-11-23 2014-05-30 F. Hoffmann-La Roche Ag Substituted heterocyclic derivatives
US9572815B2 (en) * 2013-03-15 2017-02-21 St. Jude Children's Research Hospital Methods and compositions of p27KIP1 transcriptional modulators
PL404138A1 (pl) * 2013-05-31 2014-12-08 Warszawski Uniwersytet Medyczny Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα
US20150126507A1 (en) * 2013-09-05 2015-05-07 Fate Therapeutics, Inc. Compounds to treat hearing loss
CA2929194A1 (en) * 2013-11-05 2015-05-14 F. Hoffmann-La Roche Ag 5,6,7,8-tetrahydro-5,8-methanocinnoline derivatives as rorc modulators for the treatment of autoimmune diseases
EP2871181B1 (en) * 2013-11-12 2016-10-05 Acousia Therapeutics GmbH Novel Compounds for Regeneration of Terminally-Differentiated Cells and tissues
CN105017085B (zh) 2014-04-28 2018-06-29 中国科学院上海药物研究所 一类kcnq钾通道激动剂、其制备方法和用途
ES2760373T3 (es) * 2015-02-06 2020-05-13 Univ Washington Compuestos y procedimientos para prevenir o tratar la muerte de células ciliadas sensoriales
GB201601301D0 (en) * 2016-01-25 2016-03-09 Takeda Pharmaceutical Novel compounds
EP3366683A1 (en) * 2017-02-28 2018-08-29 Acousia Therapeutics GmbH Cyclic amides, acteamides and ureas useful as potassium channel openers

Also Published As

Publication number Publication date
MX2019010169A (es) 2019-10-21
DK3484863T3 (da) 2020-09-07
HRP20201159T1 (hr) 2020-11-13
CL2021001243A1 (es) 2021-10-22
CA3238405A1 (en) 2018-09-07
US20200157072A1 (en) 2020-05-21
KR102443685B1 (ko) 2022-09-15
LT3567034T (lt) 2020-12-10
KR20210134826A (ko) 2021-11-10
KR20190105058A (ko) 2019-09-11
AU2021254653B2 (en) 2022-12-08
CN114105942B (zh) 2024-07-12
PL3484863T3 (pl) 2020-12-14
RU2020140167A3 (da) 2021-04-23
EP3366683A1 (en) 2018-08-29
JP2022166055A (ja) 2022-11-01
MX378574B (es) 2025-03-10
EP3484863A2 (en) 2019-05-22
CY1123488T1 (el) 2022-03-24
CN110312710B (zh) 2022-02-15
HRP20201961T1 (hr) 2021-02-05
CL2019002445A1 (es) 2020-03-13
PH12019550146A1 (en) 2020-06-08
PT3484863T (pt) 2020-08-27
HUE052703T2 (hu) 2021-05-28
KR102382795B1 (ko) 2022-04-05
WO2018158256A3 (en) 2018-12-13
MX2020010866A (es) 2022-02-28
IL268931B (en) 2021-10-31
SMT202100053T1 (it) 2021-03-15
JP6795713B2 (ja) 2020-12-02
RS60648B1 (sr) 2020-09-30
US20210261518A1 (en) 2021-08-26
US11884642B2 (en) 2024-01-30
IL268931A (en) 2019-10-31
CN114105942A (zh) 2022-03-01
AU2018227005A1 (en) 2019-08-22
RU2019127116A3 (da) 2021-03-31
SI3567034T1 (sl) 2021-03-31
PT3567034T (pt) 2020-12-04
PL3567034T3 (pl) 2021-05-17
CA3052359A1 (en) 2018-09-07
RS61254B1 (sr) 2021-01-29
AU2018227005B2 (en) 2021-11-11
ES2846772T3 (es) 2021-07-29
JP2020510694A (ja) 2020-04-09
EP3567034B1 (en) 2020-10-28
CY1123114T1 (el) 2021-10-29
HUE051854T2 (hu) 2021-03-29
BR112019017184B1 (pt) 2021-06-01
EP3567034A1 (en) 2019-11-13
BR112019017184A2 (pt) 2020-04-28
SMT202000471T1 (it) 2020-11-10
SI3484863T1 (sl) 2020-10-30
RU2020140167A (ru) 2020-12-16
AU2021254653A1 (en) 2021-11-18
LT3484863T (lt) 2020-07-27
JP7474289B2 (ja) 2024-04-24
CN110312710A (zh) 2019-10-08
RU2019127116A (ru) 2021-03-30
US11034665B2 (en) 2021-06-15
MX390303B (es) 2025-03-20
ZA201905198B (en) 2020-03-25
JP2021008479A (ja) 2021-01-28
CA3052359C (en) 2025-10-21
WO2018158256A2 (en) 2018-09-07
BR122020025103B1 (pt) 2021-06-01
EP3484863B1 (en) 2020-06-17
ES2813064T3 (es) 2021-03-22

Similar Documents

Publication Publication Date Title
DK3567034T3 (da) Pentacyclothienyl- og indanyl-urinstof-derivater som kaliumkanalåbnere
DK3580220T3 (da) Aminotriazolpyridiner som kinasehæmmere
EP3222107A4 (en) Channel access mechanism
EP3254154A4 (en) Optical modulating device having gate structure
EP3306582A4 (en) Gate device
DK3704118T3 (da) Aminoimidazopyrazin som kinasehæmmere
EP4241843C0 (en) ALCOHOL DERIVATIVES USED AS KV7 POTASSIUM CHANNEL OPENERS
DK3572405T3 (da) Benzoimidazol-1,2-yl-amider som kv7-kanalaktivatorer
EP3210969A4 (en) Kcnq2-5 channel activator
EP3728570A4 (en) GLYCOENGINEERING
DK3372671T3 (da) Dyrkningsmedium, som omfatter oligopeptider
DK3545158T3 (da) Rulleport
KR101881983B1 (ko) 새로운 유형의 kcnq 칼륨 통로 작동제, 그의 제조 방법 및 그의 용도
DK3439641T3 (da) Sammensætninger, kits og fremgangsmåder til opretholselse af øjenlågshygiejne
DK3571193T3 (da) Potassium Channel Modulators
EP3238267A4 (en) Thin channel region on wide subfin
EP3123786A4 (en) Channel scan based on mobility state
IT201700055726A1 (it) Porta scorrevole.
DK3191081T3 (da) Formulering, som omfatter glycopyrrolat, fremgangsmåde og indretning
DK3632413T3 (da) Langtidscirkulerende liposom, som er modificeret med c(rgd-acp-k)
EP3601989A4 (en) VERTICAL AERODYNAMIC TUNNEL OPEN
EP3135167A4 (en) Detachable device, and hinge device employing same
EP3228797B8 (de) Flucht-schiebetür
GB201717786D0 (en) Potassium channel inhibitors
IT201700028857A1 (it) Cerniera per serramenti